Penserra Capital Management LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 23 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$25,000
+78.6%
4,095
+75.0%
0.00%
+50.0%
Q4 2016$14,000
-22.2%
2,340
-7.9%
0.00%0.0%
Q3 2016$18,000
+12.5%
2,540
+33.3%
0.00%0.0%
Q2 2016$16,000
+45.5%
1,905
+9.4%
0.00%
+100.0%
Q1 2016$11,000
+10.0%
1,741
+46.1%
0.00%0.0%
Q4 2015$10,0001,1920.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders